In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Novel echocardiography techniques for heart failure
Session

Event : ESC Congress 2019

Topic : Chronic Heart Failure – Diagnostic Methods: Imaging

  • Session type : Rapid Fire Abstracts
  • Date : 02 September 2019
  • Time : 18:40 - 19:50

8 presentations in this session

Strain parameters at rest and after exercise in symptomatically stable patients with improved heart failure - STRESS-HF

Event : ESC Congress 2019

  • Session : Novel echocardiography techniques for heart failure
  • Speaker : M Saran (Lucknow,IN)

Machine-learning integration of complex echocardiographic patterns and clinical parameters from cohorts and trials

Event : ESC Congress 2019

  • Session : Novel echocardiography techniques for heart failure
  • Speaker : M Cikes (Zagreb,HR)

Revisiting the weber and ventilatory classifications in heart failure by combining exercise stress echo with gas exchange phenotyping

Event : ESC Congress 2019

  • Session : Novel echocardiography techniques for heart failure
  • Speaker : T Sugimoto (Tsu City,JP)

The interrelation of left ventricular geometry with myocardial work

Event : ESC Congress 2019

  • Session : Novel echocardiography techniques for heart failure
  • Speaker : F Sahiti (Wuerzburg,DE)

Lung ultrasound in stable ambulatory chronic heart failure patients

Event : ESC Congress 2019

  • Session : Novel echocardiography techniques for heart failure
  • Speaker : M Domingo (Barcelona,ES)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are